Draft Genome Sequence of Streptomyces clavuligerus NRRL 3585, a Producer of Diverse Secondary Metabolites
Author(s) -
Ju Yeon Song,
Haeyoung Jeong,
Dong Yu,
Michael A. Fischbach,
Hong-Seog Park,
Jae Jong Kim,
JeongSun Seo,
Susan E. Jensen,
Tae Kwang Oh,
Kye Joon Lee,
Jihyun F. Kim
Publication year - 2010
Publication title -
journal of bacteriology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.652
H-Index - 246
eISSN - 1067-8832
pISSN - 0021-9193
DOI - 10.1128/jb.00859-10
Subject(s) - streptomyces clavuligerus , biology , whole genome sequencing , genome , genetics , pyrosequencing , streptomyces , clavulanic acid , gene , plasmid , computational biology , antibiotics , actinomycetales , bacteria , amoxicillin
Streptomyces clavuligerus is an important industrial strain that produces a number of antibiotics, including clavulanic acid and cephamycin C. A high-quality draft genome sequence of the S. clavuligerus NRRL 3585 strain was produced by employing a hybrid approach that involved Sanger sequencing, Roche/454 pyrosequencing, optical mapping, and partial finishing. Its genome, comprising four linear replicons, one chromosome, and four plasmids, carries numerous sets of genes involved in the biosynthesis of secondary metabolites, including a variety of antibiotics.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom